MP36-04 CLINICAL Experience with Tlando in Hypogonadal Men (original) (raw)

AI-generated Abstract

The study presents a comprehensive clinical experience with TLANDO, an oral testosterone replacement therapy (TRT) for hypogonadal men, highlighting its efficacy and unique properties. Findings from four clinical trials indicate that TLANDO can restore testosterone levels effectively without the need for dose titration, positively impacting sexual and mental health outcomes. Documented good tolerability and safety, particularly in older patients, position TLANDO as a convenient option for initiating TRT.